Abstract
Over the past several years, evidence has been accumulated that the immune and inflammatory systems play a role in diverse diseases. This recognition has been captured in key reviews in a special issue of Nature, where the role of inflammation in diseases such as cancer, atherosclerosis, central nervous system and infections has been highlighted [1]. In this perspective, heart diseases are no exceptions. As illustrated in the book Inflammation and Cardiac Diseases, immune and inflammatory processes figure prominently in all aspects of human heart diseases — ischemia, heart failure, myocarditis, arrhythmias, and reperfusion injuries. It is, however, important to note that the role of the immune and inflammatory systems in cardiac diseases as discussed in this book focus only on cardiac diseases that are direct outcome of injuries to the heart itself, such as myocardial infarction, myocarditis, arrhythmia or idiopathic disorders of the heart. However, cardiovascular organs may become “casualties” of inflammatory processes associated with other organs. Immune and inflammatory conditions such as gingivitis, rheumatoid arthritis and systemic lupus erythematosus have been associated with increased cardiovascular morbidity and mortality [2-6]. Of particular interest are very recent observations on increased coronary neointima formation in rheumatoid arthritis patients, which could directly explain the increase risk for heart attacks via circulatory humoralmediators of inflammation [7]. These aspects of cardiac disease risk, although beyond the primary focus of the book, are inferred in several chapters such as those dealing with coronary inflammation and systemic inflammatory factors.
Keywords
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Cardiac Disease
- Inflammatory System
- Inflammatory Modulator
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nature insight, inflammation (2002) (Supplement to Nature Immunology and Nature Medicine) 420: 845–891
Symmons DP, Jones MA, Scott DL, Prior P (1998) Long term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatology 25: 1072–1077
Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DPM (2002) Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 46: 2010–2019
Del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44: 2737–2745
Hurlinmann D, Forster A, Noll G et al (2002) Anti-tumor necrosis factor alpha treat-ment improves endothelial function, in patients with rheumatoid arthritis. Circulation 106: 2184–2187
Wallberg-Jonsson S, Csvetkovic, JT, Sundqvist KG, Lefvert AK, Rantapaa- Dahlqvist S (2002) Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic diseases and atherosclerosis in rheumatoid arthritis. J Rheumatol 29: 875–882
Kumeda Y, Inaba M, Goto H et al (2002) Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 46: 1489–1497
Wang H, Yu M, Ochani M et al (2003) Nicotinic acetyl choline receptor alpha 7 sub-unit is an essential regulator of inflammation. Nature 421: 384–388
Floto AF, Smith KGC (2003) The vagus nerve, macrophages and nicotine. Lancet 361: 1069–1070
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Basel AG
About this chapter
Cite this chapter
Feuerstein, G.Z., Libby, P., Mann, D.L. (2003). Summary: Immune and inflammatory modulators as potential therapeutic targets for cardiac diseases. In: Feuerstein, G.Z., Libby, P., Mann, D.L. (eds) Inflammation and Cardiac Diseases. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8047-3_25
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8047-3_25
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9419-7
Online ISBN: 978-3-0348-8047-3
eBook Packages: Springer Book Archive